EMILIE BREEDING: Open Payments
NPI 1174077333 · MIAMISBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,963 in 162 payments from 20 companies in 2025. Trend: 2023 $13,471 · 2024 $8,624 · 2025 $15,963
Speaker / faculty: $12,550Food & beverage: $3,409Education: $4
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $8,901 |
| Neos Therapeutics, LP | 10 | $2,732 |
| AYTU BioPharma, Inc. | 3 | $1,650 |
| Axsome Therapeutics, Inc. | 28 | $840 |
| Otsuka America Pharmaceutical, Inc. | 16 | $303 |
| Alkermes, Inc. | 9 | $233 |
| Teva Pharmaceuticals USA, Inc. | 3 | $165 |
| Lundbeck LLC | 9 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $151 |
| Janssen Pharmaceuticals, Inc | 6 | $143 |
Products named: VRAYLAR, Adzenys XR-ODT, Cotempla XR-ODT, Auvelity, EXXUA, REXULTI, AUSTEDO XR, CAPLYTA.
Industry payments across OH — which companies pay providers there.
